🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Israel’s Ministry of Health on Monday began offering a 3rd dose of the Pfizer vaccine to severely immunocompromised adults in what could be the first phase of an experiment to provide booster shots for older people and the most vulnerable. washingtonpost.com/world/israel-v…

#ACR21 will build on the successes of last year’s virtual meeting while expanding engagement opportunities for participants. Learn more from Swamy Venuturupalli, MD → acr.tw/3pPEUYF

The inflammatory landscape of #COVID19 is complex in both children and adults- MIS-A is rare but devastating complication - Many lessons at #ACR21 today on disecting and treating this phase of COVID - #rheumatology peeps nned to be able to recognize MIS-A in adults Puja Mehta 🧩 🌻

Great to hear such fascinating discoveries at #ACR21 !!

Fantastic work moving this forward! Will be very useful for patients.

The ACR is aware of the emerging concerns surrounding access to needed treatments such as #MTX after the recent decision in Dobbs v. Jackson Women’s Health Organization.

I have been following the vaccine dialogue and might be accused of going rogue-but if move toward different designs and platforms for a virus that will always be here we need a massive safety study to start -NO extrapolation Paul Sax Carlos del Rio Prof Peter Hotez MD PhD DSc(hon) AJ Leonardi, MBBS, PhD

The new convergence App is awesome! Definitely improves the meeting experience. Congratulations to American College of Rheumatology AMPC team #ACR22

Happy Birthday Alfred Kim (moving to Bluesky as alhkim) !! Karaoke action happening soon @ yakatori Boy! @HsiehEvelyn #ACR22

With the woman behind the meeting! Thank you Sharon Kolasinski AMPC chair and the amazing AMPC team for an amazing #ACR22 PennRheum

Excited to be moderating this provocative session with an all star panel!

Introducing a new ACR on Air series, In Practice, where we explore ways to aid busy clinicians in their practice. Listen in as guest Swamy Venuturupalli, MD talks tech solutions designed to improve efficiency, which have proven to work for his practice Attune Health → acronair.org

New paper today! We know anti-vinculin antibodies as an important biomarker of #IBS that I use in my clinic all the time. New collaboration confirms this test is also associated with objective GI effects of #scleroderma. A marker in this terrible disease. onlinelibrary.wiley.com/doi/10.1002/ac…

Community practitioners interested in conducting #rheumresearch in a clinical practice setting are invited to apply for our Community Practice Innovation Award. Letters of intent are due by Jan 15 & applications are due by Feb 1. Learn more & apply at RheumResearch.org/CPIA

#Rheumatology practitioners interested in conducting research in a clinical setting: there are only a few days to submit your required, non-binding letter of requirement for the Community Practice Innovation Award! Learn more about how to apply at RheumResearch.org/CPIA

🎥 "ACR is the biggest show in rheumatology. It's where rheumatology meets. It's called convergence for a reason." Founder & CEO of Attune Health, Swamy Venuturupalli, MD, shares his excitement for #ACR24—especially learning about CAR T cell therapies for lupus and bringing insights back to

Dr. Swamy Venuturupalli, a Community Practice Innovation Award recipient, is transforming telehealth in rheumatology! His project introduces an innovative app that empowers patients to examine their own joints—making high-quality telehealth a seamless part of care.